Emerging role of serpinE2/protease nexin-1 in hemostasis and vascular biology

Blood

Volumn 119, Issue 11, 2012, Pages 2452-2457

  Bouton, Marie Christine ^a,b   Boulaftali, Yacine ^a,b   Richard, Benjamin ^a,b   Arocas, Véronique ^a,b   Michel, Jean Baptiste ^a,b   Jandrot Perrus, Martine ^a,b  

^a INSERM   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11A; FIBRIN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; PLASMIN; PLASMINOGEN ACTIVATOR; PROTEASE NEXIN I; SERINE PROTEINASE INHIBITOR; SERPINE2; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TRYPSIN; UNCLASSIFIED DRUG; UROKINASE; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; BLOOD CLOT LYSIS; BLOOD VESSEL INJURY; ENZYME ACTIVITY; FIBRINOLYSIS; HEMOSTASIS; HUMAN; IMMUNOHISTOCHEMISTRY; MONOCYTE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE; THROMBOCYTE RICH PLASMA; THROMBOSIS; VASCULAR BIOLOGY; VASCULAR DISEASE;

EID: 84858650650     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-387464     Document Type: Review

References (50)

1. Silverman GA, Bird PI, Carrell RW, et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem. 2001;276(36):33293-33296.
2. Rau JC, Beaulieu LM, Huntington JA, Church FC. Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost. 2007;5 suppl 1:102-115. (Pubitemid 46958823)
3. Dellas C, Loskutoff DJ. Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost. 2005;93(4):631-640. (Pubitemid 40485397)
4. Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010;28(5):e72-e91.
5. Fay WP, Garg N, Sunkar M. Vascular functions of the plasminogen activation system. Arterioscler Thromb Vasc Biol. 2007;27(6):1231-1237. (Pubitemid 46809410)
6. Sommer J, Gloor SM, Rovelli GF, et al. cDNA sequence coding for a rat glia-derived nexin and its homology to members of the serpin superfamily. Biochemistry. 1987;26(20):6407-6410.
7. Evans DL, McGrogan M, Scott RW, Carrell RW. Protease specificity and heparin binding and activation of recombinant protease nexin I. J Biol Chem. 1991;266(33):22307-22312. (Pubitemid 21908652)
8. McGrogan M, Kennedy J, Li MP, et al. Molecular cloning and expression of two forms of human protease nexin I. Biotechnology. 1988;6:172-177.
9. Huntington JA. Serpin structure, function and dysfunction. J Thromb Haemost. 2011;9 suppl 1:26-34.
10. Nick H, Hofsteenge J, Shaw E, Rovelli G, Monard D. Functional sites of glia-derived nexin (GDN): importance of the site reacting with the protease. Biochemistry. 1990;29(9):2417-2421. (Pubitemid 20095487)
11. Scott RW, Bergman BL, Bajpai A, et al. Protease nexin. Properties and a modified purification procedure. J Biol Chem. 1985;260(11):7029-7034. (Pubitemid 15016093)
12. Knauer DJ, Majumdar D, Fong PC, Knauer MF. SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor. J Biol Chem. 2000;275(48):37340-37346. (Pubitemid 32004836)
13. Hermans JM, Stone SR. Interaction of activated protein C with serpins. Biochem J. 1993;295(pt 1):239-245. (Pubitemid 23298333)
14. Muhl L, Nykjaer A, Wygrecka M, Monard D, Preissner KT, Kanse SM. Inhibition of PDGF-BB by factor VII-activating protease (FSAP) is neutralized by protease nexin-1, and the FSAPinhibitor complexes are internalized via LRP. Biochem J. 2007;404(2):191-196. (Pubitemid 46849590)
15. Richard B, Bouton MC, Loyau S, et al. Modulation of protease nexin-1 activity by polysaccharides. Thromb Haemost. 2006;95(2):229-235.
16. Stone SR, Brown-Luedi ML, Rovelli G, Guidolin A, McGlynn E, Monard D. Localization of the heparinbinding site of glia-derived nexin/protease nexin-1 by site-directed mutagenesis. Biochemistry. 1994;33(24):7731-7735. (Pubitemid 24230599)
17. Stone SR, Nick H, Hofsteenge J, Monard D. Glial-derived neurite-promoting factor is a slow-binding inhibitor of trypsin, thrombin, and urokinase. Arch Biochem Biophys. 1987;252(1):237-244. (Pubitemid 17006015)
18. Wallace A, Rovelli G, Hofsteenge J, Stone SR. Effect of heparin on the glia-derived-nexinthrombin interaction. Biochem J. 1989;257(1):191-196.
19. Rovelli G, Stone SR, Guidolin A, Sommer J, Monard D. Characterization of the heparin-binding site of glia-derived nexin/protease nexin-1. Biochemistry. 1992;31(13):3542-3549.
20. Crisp RJ, Knauer DJ, Knauer MF. Roles of the heparin and low density lipid receptor-related protein- binding sites of protease nexin 1 (PN1) in urokinase-PN1 complex catabolism. The PN1 heparin-binding site mediates complex retention and degradation but not cell surface binding or internalization. J Biol Chem. 2000;275(26):19628-19637. (Pubitemid 30441557)
21. Knauer MF, Kridel SJ, Hawley SB, Knauer DJ. The efficient catabolism of thrombin-protease nexin 1 complexes is a synergistic mechanism that requires both the LDL receptor-related protein and cell surface heparins. J Biol Chem. 1997;272(46):29039-29045. (Pubitemid 27498190)
22. Baker JB, Gronke RS. Protease nexins and cellular regulation. Semin Thromb Hemost. 1986;12(3):216-220. (Pubitemid 17198755)
23. Mansuy IM, van der Putten H, Schmid P, Meins M, Botteri FM, Monard D. Variable and multiple expression of protease nexin-1 during mouse organogenesis and nervous system development. Development. 1993;119(4):1119-1134. (Pubitemid 23358581)
24. Ernø H, Kury P, Nitsch C, Jost JP, Monard D. Excitotoxic brain lesion modifies binding to a USF binding site acting as a negative regulatory element in the protease nexin-1 promoter. Mol Cell Neurosci. 1996;8(1):28-37. (Pubitemid 26398714)
25. Verdière-Sahuquè M, Akaaboune M, Lachkar S, et al. Myoblast fusion promotes the appearance of active protease nexin I on human muscle cell surfaces. Exp Cell Res. 1996;222(1):70-76. (Pubitemid 26043713)
26. Guttridge DC, Lau AL, Cunningham DD. Protease nexin-1, a thrombin inhibitor, is regulated by interleukin- 1 and dexamethasone in normal human fibroblasts. J Biol Chem. 1993;268(25):18966-18974. (Pubitemid 23273847)
27. Vaughan PJ, Cunningham DD. Regulation of protease nexin-1 synthesis and secretion in cultured brain cells by injury-related factors. J Biol Chem. 1993;268(5):3720-3727. (Pubitemid 23071020)
28. Choi BH, Suzuki M, Kim T, Wagner SL, Cunningham DD. Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases. Am J Pathol. 1990;137(4):741-747. (Pubitemid 20337788)
29. Bouton MC, Richard B, Rossignol P, et al. The serpin protease-nexin 1 is present in rat aortic smooth muscle cells and is upregulated in L-NAME hypertensive rats. Arterioscler Thromb Vasc Biol. 2003;23(1):142-147. (Pubitemid 36091639)
30. Mansilla S, Boulaftali Y, Venisse L, et al. Macrophages and platelets are the major source of protease nexin-1 in human atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 2008;28(10):1844-1850.
31. Leroy-Viard K, Jandrot-Perrus M, Tobelem G, Guillin MC. Covalent binding of human thrombin to a human endothelial cell-associated protein. Exp Cell Res. 1989;181(1):1-10. (Pubitemid 19072786)
32. Farrell DH,Wagner SL, Yuan RH, Cunningham DD. Localization of protease nexin-1 on the fibroblast extracellular matrix. J Cell Physiol. 1988;134(2):179-188. (Pubitemid 18065895)
33. Richard B, Arocas V, Guillin MC, Michel JB, Jandrot-Perrus M, Bouton MC. Protease nexin-1: a cellular serpin down-regulated by thrombin in rat aortic smooth muscle cells. J Cell Physiol. 2004;201(1):138-145. (Pubitemid 39187052)
34. Gronke RS, Knauer DJ, Veeraraghavan S, Baker JB. A form of protease nexin I is expressed on the platelet surface during platelet activation. Blood. 1989;73(2):472-478. (Pubitemid 19060531)
35. Boulaftali Y, Adam F, Venisse L, et al. Anticoagulant and antithrombotic properties of platelet protease nexin-1. Blood. 2010;115(1):97-106.
36. Lüthi A, Van der Putten H, Botteri FM, et al. Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation. J Neurosci. 1997;17(12):4688-4699. (Pubitemid 27246926)
37. Levi M, Biemond BJ, van Zonneveld AJ, ten Cate JW, Pannekoek H. Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation. 1992;85(1):305-312.
38. Potter van Loon BJ, Rijken DC, Brommer EJ, van der Maas AP. The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility. Thromb Haemost. 1992;67(1):101-105.
39. Fay WP, Eitzman DT, Shapiro AD, Madison EL, Ginsburg D. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms. Blood. 1994;83(2):351-356. (Pubitemid 24030558)
40. Boulaftali Y, Ho-Tin-Noe B, Pena A, et al. Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis. Circulation. 2011;123(12):1326-1334.
41. Keijer J, Linders M, van Zonneveld AJ, Ehrlich HJ, de Boer JP, Pannekoek H. The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance. Blood. 1991;78(2):401-409.
42. Bouton MC, Venisse L, Richard B, Pouzet C, Arocas V, Jandrot-Perrus M. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect. Circ Res. 2007;100(8):1174-1181. (Pubitemid 46684130)
43. Rossignol P, Bouton MC, Jandrot-Perrus M, et al. A paradoxical pro-apoptotic effect of thrombin on smooth muscle cells. Exp Cell Res. 2004;299(2):279-285. (Pubitemid 39179796)
44. Meilhac O, Ho-Tin-Noe B, Houard X, Philippe M, Michel JB, Angles-Cano E. Pericellular plasmin induces smooth muscle cell anoikis. FASEB J. 2003;17(10):1301-1303.
45. Kanse SM, Parahuleva M, Muhl L, Kemkes-Matthes B, Sedding D, Preissner KT. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis. Thromb Haemost. 2008;99(2):286-289. (Pubitemid 351230957)
46. Richard B, Pichon S, Arocas V, et al. The serpin protease nexin-1 regulates vascular smooth muscle cell adhesion, spreading, migration and response to thrombin. J Thromb Haemost. 2006;4(2):322-328.
47. Rovelli G, Stone SR, Preissner KT, Monard D. Specific interaction of vitronectin with the cell-secreted protease inhibitor glia-derived nexin and its thrombin complex. Eur J Biochem. 1990;192(3):797-803. (Pubitemid 20316886)
48. Kanse SM, Chavakis T, Al-Fakhri N, Hersemeyer K, Monard D, Preissner KT. Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1. J Cell Sci. 2004;117(Pt 3):477-485. (Pubitemid 38181209)
49. Borges LF, Gomez D, Quintana M, et al. Fibrinolytic activity is associated with presence of cystic medial degeneration in aneurysms of the ascending aorta. Histopathology. 2010;57(6):917-932.
50. Murer V, Spetz JF, Hengst U, Altrogge LM, de Agostini A, Monard D. Male fertility defects in mice lacking the serine protease inhibitor protease nexin-1. Proc Natl Acad Sci U S A. 2001;98(6):3029-3033. (Pubitemid 32223492)